Latest news
CLRB Stock Surged 27% Today – Here’s Why Retail Is Bullish About Cellectar’s Blood Cancer Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 09:53:06 GMTEmpery Asset Management (CLRB) discloses 9.99% beneficial stake via stock and warrants - Stock TitanStock Titan · Tue, 04 Aug 2026 14:06:32 GMTCLRB|Cellectar Biosciences Inc|Price:2.595|Chg%:+0.025 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTCLRB Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 32% - Earnings Quality Analysis - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 04:40:33 GMTCellectar Biosciences to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 13 - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 12:15:00 GMTCellectar Biosciences to Report Second Quarter Financial - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 12:05:00 GMTCellectar Biosciences Inc (CLRB) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 05:41:06 GMTCellectar Biosciences Inc (CLRB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Mon, 27 Jul 2026 01:14:18 GMT